Revolutionizing Pancreatic Cancer Diagnosis: Mayo Clinic Study Reveals KRAS ctDNA as a Powerful Predictor of Metastasis and Poor Prognosis, Enabling Personalized Treatment Strategies
A new study has found that pancreatic cancer cells are different based on their location in the pancreas, providing new information about tumors that could lead to better targeted treatments.